Readystate Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-641
Closed -$529K 791
2025
Q1
$529K Sell
641
-170
-21% -$141K 0.02% 453
2024
Q4
$626K Buy
811
+140
+21% +$116K 0.02% 442
2024
Q3
$594K Buy
+671
New +$603K 0.01% 453
2024
Q1
Sell
-293
Closed -$209K 954
2023
Q4
$171K Buy
+293
New +$171K 0.01% 542

Other funds holding LLY

Readystate Asset Management's LLY Position: Q2 2025 in Review

Readystate Asset Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 641 shares — an estimated $529K sold.

Readystate Asset Management first reported a position in LLY in Q4 2023 and held it in 4 quarters. The position peaked at $626K in Q4 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Readystate Asset Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 641 Eli Lilly shares in Q2 2025, an estimated $529K.
  • Readystate Asset Management first reported a position in Eli Lilly in Q4 2023 and held it in 4 quarters.
  • Readystate Asset Management's Eli Lilly position peaked at $626K in Q4 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.